MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Vertex Pharmaceuticals Incorporated Company Profile (NASDAQ:VRTX)

Consensus Ratings for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) (?)
Ratings Breakdown: 7 Hold Rating(s), 18 Buy Rating(s)
Consensus Rating:Buy (Score: 2.72)
Consensus Price Target: $128.14 (50.75% upside)

Analysts' Ratings History for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Show:
DateFirmActionRatingPrice TargetActions
6/18/2016Piper JaffrayReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/17/2016Jefferies GroupReiterated RatingBuy$103.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/16/2016Credit SuisseReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2016Morgan StanleyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2016Robert W. BairdReiterated RatingOutperform$144.00 -> $128.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Needham & Company LLCReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016HC WainwrightReiterated RatingBuy$155.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Maxim GroupReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016BarclaysLower Price TargetOverweight$135.00 -> $110.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Goldman SachsDowngradeBuy -> Neutral$109.00 -> $88.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016RBC CapitalLower Price TargetOutperform$135.00 -> $115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2016Cowen and CompanyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/7/2016BMO Capital MarketsInitiated CoverageMarket Perform$90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/4/2016JPMorgan Chase & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2016Stifel NicolausLower Price TargetBuy$140.00 -> $108.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016GuggenheimLower Price TargetBuy$145.00 -> $114.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016Bank of AmericaReiterated RatingNeutral$108.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016OppenheimerInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016ArgusLower Price TargetBuy$154.00 -> $140.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/27/2015William BlairReiterated RatingBuy$158.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/26/2015JMP SecuritiesLower Price TargetMarket Outperform$140.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/15/2015NomuraInitiated CoverageBuy$162.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2015Deutsche BankReiterated RatingBuy$155.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/7/2015BTIG ResearchLower Price TargetBuy$200.00 -> $180.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/5/2015Canaccord GenuityReiterated RatingBuy$150.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2015Citigroup Inc.Boost Price TargetBuy$141.00 -> $156.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/9/2015Janney Montgomery ScottInitiated CoverageNeutral$126.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2014CRT CapitalInitiated CoverageBuy$175.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2014Wells FargoUpgradeNeutral -> Outperform$129.00 -> $125.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/27/2016        
4/27/2016Q116$0.29$0.09$439.94 million$398.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2016Q4$0.17$0.17$406.30 million$417.94 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2015Q315($0.60)($0.13)$245.84 million$309.82 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2015Q215($0.58)($0.54)$149.49 million$166.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2015Q115($0.75)($0.62)$142.38 million$138.51 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2015Q414($0.65)($0.55)$137.50 million$144.56 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2014Q314($0.62)($0.37)$146.20 million$179.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2014Q214($0.71)($0.61)$131.85 million$138.42 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014Q114($0.68)($0.65)$134.46 million$118.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2014Q413($0.49)($0.56)$221.08 million$351.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2013Q413($0.33)($0.32)$278.80 million$222.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2013Q2 2013($0.18)($0.26)$308.02 million$310.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2013Q1 2013($0.06)$0.03$307.85 million$328.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2013Q4 2012($0.07)($0.35)$318.53 million$334.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2012Q312$0.34$0.13$377.14 million$336.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2012$0.68$0.46ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2012$0.57$0.43ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/2/2012$0.76$0.74ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2011$0.17$0.70ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2011($1.00)($0.67)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011($1.09)($0.91)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2011($0.93)($0.74)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
1/29/2013quarterly$0.402/20/20133/13/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/22/2016Joshua S BogerDirectorSell5,130$86.61$444,309.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2016Joshua S BogerDirectorSell5,130$91.18$467,753.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/8/2016Joshua S BogerDirectorSell5,130$94.95$487,093.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2016Joshua S BogerDirectorSell5,130$93.65$480,424.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/25/2016Joshua S BogerDirectorSell5,130$89.09$457,031.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2016Joshua S BogerDirectorSell5,130$81.18$416,453.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016Amit SachdevEVPSell117$81.67$9,555.39View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016Ian F SmithCFOSell202$82.06$16,576.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/11/2016Joshua S BogerDirectorSell5,130$86.50$443,745.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2016Paul M SilvaSVPSell3,000$87.63$262,890.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/4/2016Joshua S BogerDirectorSell5,130$81.02$415,632.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2016Joshua S BogerDirectorSell5,130$83.67$429,227.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/20/2016Joshua S BogerDirectorSell5,130$84.10$431,433.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/13/2016Joshua S BogerDirectorSell5,130$84.27$432,305.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2016Joshua S BogerDirectorSell5,130$89.56$459,442.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/30/2016Joshua S BogerDirectorSell5,130$78.83$404,397.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/23/2016Joshua S BogerDirectorSell5,130$81.38$417,479.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2016Joshua S BogerDirectorSell5,130$79.65$408,604.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2016Joshua S BogerDirectorSell5,130$91.80$470,934.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2016Joshua S BogerDirectorSell5,130$85.25$437,332.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2016Joshua S. BogerDirectorSell5,130$86.93$445,950.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2016Joshua S. BogerDirectorSell5,130$82.57$423,584.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2016Ian F. SmithCFOSell12,084$90.84$1,097,710.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2016Jeffrey M. LeidenCEOSell9,834$90.82$893,123.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2016Joshua S. BogerDirectorSell5,130$90.81$465,855.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2016Paul M. SilvaSVPSell5,062$90.82$459,730.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2016Stuart A. ArbuckleEVPSell6,042$90.82$548,734.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2016Jeffrey ChodakewitzCMOSell2,375$91.38$217,027.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/27/2016Joshua S. BogerDirectorSell11,200$93.22$1,044,064.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/20/2016Joshua S. BogerDirectorSell10,400$93.69$974,376.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/13/2016Joshua S. BogerDirectorSell10,400$98.41$1,023,464.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/6/2016Joshua S. BogerDirectorSell10,400$121.96$1,268,384.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Yuchun LeeDirectorSell1,125$122.21$137,486.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/30/2015Joshua S. BogerDirectorSell10,400$127.15$1,322,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/21/2015Joshua S. BogerDirectorSell10,400$119.26$1,240,304.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2015Joshua S. BogerDirectorSell10,400$120.80$1,256,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2015Stuart A. ArbuckleEVPSell4,531$123.98$561,753.38View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2015Joshua S. BogerDirectorSell10,400$130.91$1,361,464.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2015David AltshulerEVPSell5,000$131.00$655,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2015Yuchun LeeDirectorSell1,125$129.65$145,856.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/23/2015Joshua S. BogerDirectorSell10,400$132.18$1,374,672.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2015Joshua S. BogerDirectorSell10,400$118.59$1,233,336.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2015Joshua S. BogerDirectorSell10,400$124.23$1,291,992.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2015Yuchun LeeDirectorSell1,125$126.19$141,963.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2015Joshua S. BogerDirectorSell10,400$119.01$1,237,704.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/21/2015Joshua S. BogerDirectorSell10,400$108.82$1,131,728.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/14/2015Joshua S. BogerDirectorSell10,400$112.62$1,171,248.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/7/2015Joshua S. BogerDirectorSell10,400$109.61$1,139,944.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/2/2015Elaine UllianDirectorSell20,000$110.00$2,200,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2015Stuart A. ArbuckleEVPSell12,417$104.71$1,300,184.07View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2015Yuchun LeeDirectorSell1,125$104.64$117,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/30/2015Joshua S. BogerDirectorSell10,400$103.14$1,072,656.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/23/2015Joshua S. BogerDirectorSell10,400$111.89$1,163,656.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2015Joshua S. BogerDirectorSell10,400$133.24$1,385,696.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2015Joshua S. BogerDirectorSell10,400$131.41$1,366,664.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2015Stuart A. ArbuckleEVPSell9,063$125.77$1,139,853.51View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2015Joshua S. BogerDirectorSell10,400$125.85$1,308,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/1/2015Yuchun LeeDirectorSell1,125$125.40$141,075.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2015Joshua S. BogerDirectorSell10,400$124.71$1,296,984.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2015Joshua S. BogerDirectorSell10,400$139.93$1,455,272.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2015Joshua S BogerDirectorSell10,400$135.83$1,412,632.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2015Joshua S BogerDirectorSell10,400$130.92$1,361,568.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2015Joshua S BogerDirectorSell12,200$133.98$1,634,556.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/13/2015Paul M SilvaSVPSell1,125$123.79$139,263.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/8/2015Joshua S BogerDirectorSell11,700$122.74$1,436,058.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/2/2015Jeffrey ChodakewitzCMOSell2,291$129.36$296,363.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015Joshua S BogerDirectorSell11,700$125.60$1,469,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/24/2015Joshua S BogerDirectorSell11,700$130.41$1,525,797.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2015Joshua S BogerDirectorSell11,700$123.90$1,449,630.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2015Joshua S BogerDirectorSell11,700$125.02$1,462,734.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2015Joshua S BogerDirectorSell11,700$126.73$1,482,741.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2015Joshua S BogerDirectorSell11,700$122.79$1,436,643.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2015Paul M SilvaSVPSell4,101$123.68$507,211.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2015Joshua S BogerDirectorSell11,700$124.59$1,457,703.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2015Paul M SilvaSVPSell1,125$129.74$145,957.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2015Stuart A ArbuckleEVPSell61,480$129.36$7,953,052.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2015Terrence C KearneyDirectorSell68,125$129.11$8,795,618.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/22/2015Joshua S BogerDirectorSell11,700$132.46$1,549,782.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2015Joshua S BogerDirectorSell11,700$129.25$1,512,225.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/13/2015Paul M SilvaSVPSell1,125$128.60$144,675.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2015Joshua S BogerDirectorSell11,700$123.26$1,442,142.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2015Margaret G McglynnDirectorSell12,500$118.36$1,479,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/2/2015Jeffrey ChodakewitzCMOSell2,291$115.50$264,610.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2015Joshua S BogerDirectorSell11,700$115.87$1,355,679.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/25/2015Joshua S BogerDirectorSell11,700$120.76$1,412,892.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/23/2015Amit SachdevEVPSell17,083$132.28$2,259,739.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/23/2015Ian F SmithCFOSell6,042$125.67$759,298.14View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/23/2015Paul M SilvaSVPSell2,250$125.65$282,712.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2015Amit SachdevEVPSell12,000$130.00$1,560,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2015Paul M SilvaSVPSell1,688$109.75$185,258.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2015Joshua S BogerDirectorSell5,700$108.81$620,217.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2015Paul M SilvaSVPSell2,063$108.89$224,640.07View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2015Jeffrey ChodakewitzCMOSell1,188$109.60$130,204.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/28/2015Joshua S BogerDirectorSell10,688$122.78$1,312,272.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/26/2015Paul M SilvaSVPSell1,125$125.62$141,322.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/21/2015Joshua S BogerDirectorSell10,500$125.08$1,313,340.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/14/2015Joshua S BogerDirectorSell10,500$120.16$1,261,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2015Amit SachdevEVPSell12,000$125.00$1,500,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2015Bruce I SachsDirectorSell9,861$125.04$1,233,019.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2015Joshua S BogerDirectorSell10,500$119.32$1,252,860.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Jeffrey ChodakewitzCMOSell2,291$122.54$280,739.14View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/22/2014Joshua S BogerDirectorSell10,500$117.65$1,235,325.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2014Joshua S BogerDirectorSell10,500$110.66$1,161,930.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Jeffrey M LeidenCEOSell50,017$114.97$5,750,454.49View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2014Paul M SilvaSVPSell2,813$120.08$337,785.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/28/2014Amit SachdevEVPSell12,000$120.00$1,440,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/28/2014Bruce I SachsDirectorSell10,000$120.03$1,200,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/28/2014Paul M SilvaSVPSell8,164$119.85$978,455.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2014Joshua S BogerDirectorSell10,500$114.54$1,202,670.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2014Bruce I SachsDirectorSell9,900$115.21$1,140,579.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/5/2014Bruce I SachsDirectorSell30,100$112.62$3,389,862.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Joshua S BogerDirectorSell127,411$112.20$14,295,514.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2014Joshua S BogerDirectorSell10,500$109.44$1,149,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2014Amit SachdevEVPSell12,000$115.00$1,380,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2014David AltshulerDirectorSell2,000$114.75$229,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2014Jeffrey ChodakewitzCMOSell3,438$115.00$395,370.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/27/2014Paul M SilvaSVPSell1,125$110.03$123,783.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/13/2014Paul M SilvaSVPSell1,125$107.89$121,376.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/7/2014Jeffrey ChodakewitzCMOSell3,436$104.26$358,237.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/6/2014David AltshulerDirectorSell1,405$109.75$154,198.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Elaine UllianDirectorSell5,000$107.74$538,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Stuart A ArbuckleEVPSell12,417$107.71$1,337,435.07View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/30/2014Amit SachdevSVPSell86,000$112.68$9,690,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/30/2014Ian F SmithCFOSell108,026$112.68$12,172,369.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/30/2014Jeffrey M LeidenCEOSell200,000$112.69$22,538,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/30/2014Kenneth L HortonEVPSell36,000$112.69$4,056,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/29/2014David AltshulerDirectorSell2,500$114.75$286,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/24/2014Joshua S BogerDirectorSell5,200$109.21$567,892.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/19/2014David AltshulerDirectorSell5,000$102.25$511,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/19/2014Paul M SilvaSVPSell25,408$99.85$2,536,988.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/19/2014Stuart A ArbuckleEVPSell55,521$100.00$5,552,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2014Joshua S BogerDirectorSell5,200$93.62$486,824.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2014Joshua S BogerDirectorSell5,200$94.42$490,984.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2014David AltshulerDirectorSell2,500$94.75$236,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2014Joshua S BogerDirectorSell5,200$92.79$482,508.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014Joshua S BogerDirectorSell5,200$93.31$485,212.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2014Joshua S BogerDirectorSell5,200$91.51$475,852.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2014Joshua S BogerDirectorSell5,200$88.00$457,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/6/2014Joshua S BogerDirectorSell5,200$86.54$450,008.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/31/2014David AltshulerDirectorSell5,000$89.59$447,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/31/2014Paul M SilvaSVPSell2,027$88.97$180,342.19View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2014Joshua S BogerDirectorSell5,200$92.17$479,284.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2014Wayne Joseph RileyDirectorSell4,800$96.65$463,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Elaine UllianDirectorSell5,000$95.21$476,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Kenneth L HortonEVPSell30,134$95.22$2,869,359.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/24/2014Megan E PaceSVPSell12,734$98.03$1,248,314.02View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/24/2014Wayne Joseph RileyDirectorSell15,000$98.03$1,470,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014Peter MuellerEVPSell7,500$68.31$512,325.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2014Elaine UllianDirectorSell2,500$75.00$187,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2014Peter MuellerEVPSell7,500$67.45$505,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2014Megan PaceSVPSell1,000$67.62$67,620.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2014Peter MuellerEVPSell7,500$61.63$462,225.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/9/2014Elaine UllianDirectorSell2,500$70.00$175,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/21/2014Bruce SachsDirectorSell8,700$74.59$648,933.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2014Peter MuellerEVPSell7,500$78.29$587,175.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/7/2014Jeffrey LeidenCEOSell35,944$80.00$2,875,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/22/2014Bruce SachsDirectorSell8,300$84.47$701,101.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/21/2014Megan PaceSVPSell1,250$85.00$106,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2014Jeffrey LeidenCEOSell45,000$80.00$3,600,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2014Peter MuellerEVPSell7,500$78.67$590,025.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/23/2013Bruce SachsDirectorSell8,300$73.02$606,066.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2013Peter MuellerEVPSell7,500$64.69$485,175.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2013Jeffrey LeidenCEOSell9,834$65.48$643,930.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2013Kenneth HortonEVPSell4,532$65.46$296,664.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2013Megan PaceSVPSell5,083$65.48$332,834.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2013Joshua BogerDirectorSell1,400$67.48$94,472.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2013Joshua BogerDirectorSell1,400$66.89$93,646.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2013Bruce SachsDirectorSell8,300$65.28$541,824.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2013Joshua BogerDirectorSell1,400$62.31$87,234.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/5/2013Joshua BogerDirectorSell1,400$65.64$91,896.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2013Joshua S BogerDirectorSell1,400$75.42$105,588.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2013Thomas ConnollySVPSell1,688$75.04$126,667.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/24/2013Bruce I SachsDirectorSell8,300$77.06$639,598.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/23/2013Joshua S BogerDirectorSell1,400$76.77$107,478.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/16/2013Joshua S BogerDirectorSell1,400$75.41$105,574.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/15/2013Peter MuellerEVPSell7,500$73.25$549,375.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/14/2013Paul SilvaSVPSell1,593$71.87$114,488.91View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/9/2013Joshua BogerDirectorSell1,400$72.35$101,290.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/25/2013Joshua BogerDirectorSell1,400$74.72$104,608.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2013Joshua BogerDirectorSell1,400$77.43$108,402.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2013Peter MuellerEVPSell7,500$77.22$579,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2013Joshua BogerDirectorSell1,400$79.61$111,454.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2013Joshua BogerDirectorSell1,400$75.45$105,630.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/29/2013Bruce SachsDirectorSell8,300$77.19$640,677.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2013Joshua BogerDirectorSell1,400$76.24$106,736.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/21/2013Joshua BogerDirectorSell1,400$76.96$107,744.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2013Peter MuellerEVPSell7,500$77.41$580,575.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Joshua BogerDirectorSell1,400$77.18$108,052.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2013Joshua BogerDirectorSell1,400$77.84$108,976.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2013Paul SilvaSVPSell3,001$78.90$236,778.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/31/2013Joshua S BogerDirectorSell1,400$80.89$113,246.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/29/2013Wayne Joseph RileyDirectorSell9,800$80.09$784,882.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2013Paul M SilvaSVPSell1,125$86.49$97,301.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/24/2013Bruce I SachsDirectorSell8,300$85.50$709,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/19/2013Amit SachdevSVPSell22,250$88.69$1,973,352.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/18/2013Joshua S BogerDirectorSell1,400$86.12$120,568.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/16/2013Paul M SilvaSVPSell2,063$86.25$177,933.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2013Christiana StamoulisSVPSell1,125$86.35$97,143.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2013Peter MuellerEVPSell7,500$86.34$647,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/12/2013Megan E PaceSVPSell10,678$85.00$907,630.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/11/2013Joshua S BogerDirectorSell1,400$83.83$117,362.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/8/2013Kenneth L HortonEVPSell1,813$80.72$146,345.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/8/2013Megan E PaceSVPSell28,703$80.89$2,321,785.67View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/5/2013Christiana StamoulisSVPSell4,687$81.21$380,631.27View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/3/2013Joshua S BogerDirectorSell1,400$80.20$112,280.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/2/2013Peter MuellerEVPSell122,300$79.80$9,759,540.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/26/2013Joshua S BogerDirectorSell1,400$78.59$110,026.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/21/2013Bruce I SachsDirectorSell8,300$75.93$630,219.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2013Joshua S BogerDirectorSell1,400$79.11$110,754.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2013Joshua S BogerDirectorSell1,400$81.19$113,666.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2013Joshua S BogerDirectorSell1,400$77.15$108,010.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/30/2013Joshua S BogerDirectorSell1,400$82.47$115,458.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2013Joshua S BogerDirectorSell1,400$79.72$111,608.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2013Joshua S BogerDirectorSell1,400$79.36$111,104.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2013Bruce I SachsDirectorSell60,000$81.15$4,869,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/26/2012Joshua S BogerDirectorSell4,000$41.86$167,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/7/2012Margaret G McglynnDirectorBuy1,000$45.50$45,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/8/2012Ian F SmithCFOSell44,787$60.00$2,687,220.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/3/2012Joshua S BogerDirectorSell4,000$57.74$230,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2012Joshua S BogerDirectorSell4,000$54.70$218,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
DateHeadline
06/29/16 09:50 AMVertex Pharmaceuticals Incorporated (NASDAQ:VRTX): Taking a look at the Consensus Estimates from Analysts - Telanagana Press
06/27/16 06:58 PMWatching Stock Sentiment for:Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - Press Telegraph
06/27/16 06:04 AMVertex Is A Buy - Seeking Alpha
06/24/16 07:10 PMConsensus View on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock and Check on Movement - Press Telegraph
06/24/16 09:47 AMVertex Pharmaceuticals Incorporated (VRTX) Pops 3.5% for June 23
06/23/16 07:58 PMVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Broker Rating Update - Engelwood Daily
06/23/16 07:58 PMVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Analyst Rating Consensus - Trade Calls
06/22/16 07:03 PMClaire's Place Foundation Receives Grant From Vertex Pharmaceuticals
06/22/16 06:16 AMStrong Buy Calls Count For Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) At 9 - Investor Newswire
06/21/16 10:41 AMVertex Pharmaceuticals, Inc. – Value Analysis (NASDAQ:VRTX) : June 21, 2016 -
06/20/16 07:30 AMVertex Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : VRTX-US : June 20, 2016 -
06/18/16 06:06 PMVertex Pharmaceuticals Incorporated : (VRTX) Stock Rating Reaffirmed by Jefferies Group
06/16/16 07:20 PMEarnings Analysis to see: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Flowserve Corp. (NYSE:FLS) - Beacon Chronicle
06/15/16 07:03 PMAnalyst Opinion on these Stocks: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), The Hershey Company ... - Beacon Chronicle
06/15/16 03:36 PMVERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Change in Directors or Principal Officers -
06/13/16 06:39 PMActive Watchful Movers- Tesla Motors (NASDAQ:TSLA), Vertex Pharmaceuticals (NASDAQ:VRTX), Gevo (NASDAQ ... - Seneca Globe
06/13/16 06:39 PMUpbeat Stocks in Focus- Galena Biopharma (NASDAQ:GALE), Vertex Pharmaceuticals (NASDAQ:VRTX), Gevo ... - Seneca Globe
06/13/16 06:39 PMHC Stocks Alerts: Medivation Inc (NASDAQ:MDVN), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - share market updates (press release)
06/12/16 07:14 PMVertex Pharma (VRTX) Announces Presentations of KALYDECO and ORKAMBI Data at ECFS
06/12/16 10:04 AM11:04 am Vertex Pharma presents new data for Kalydeco & Orkambi showing long-term impact of Orkambi across multiple measures of disease at the European Cystic Fibrosis Society Conference -
06/10/16 07:35 PMVertex Pharma (VRTX) Announces Presentations of KALYDECO and ORKAMBI Data at ECFS - StreetInsider.com
06/10/16 02:58 PMDownside Ahead For Biotech Stocks? -
06/10/16 10:02 AMVertex Announces Presentations of Data for KALYDECO® (ivacaftor) and ORKAMBI® (lumacaftor/ivacaftor) at European Cystic Fibrosis Society (ECFS) Conference - [Business Wire] - Vertex Pharmaceuticals Incorporated today announced presentations of KALYDECO® and ORKAMBI® data at the 39th European Cystic Fibrosis Society Conference, being held June 8 to 11, 2016 in Basel, Switzerland.
06/09/16 07:47 PMPrice Target Summary Report: 3M Company (NYSE:MMM), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - Beacon Chronicle
06/09/16 07:47 PMVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Fundamental Star Rating Report - CML News
06/09/16 10:18 AMVertex Pharma. To Participate At Goldman Sachs Conference; Webcast At 1:40 PM
06/09/16 10:18 AMLook Under The Hood: XLV Has 13% Upside
06/07/16 07:27 PMVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Earns Rating Score Of 1.72 - RealistInvestor.com
06/07/16 12:45 PM​A look inside the fantastic pill-making machine at Vertex Pharmaceuticals -
06/07/16 09:10 AMStock Market News for June 07, 2016 -
06/06/16 07:21 PMVERTEX PHARMACEUTICALS INCORPORATED (NASDAQ:VRTX) Financial Condition Compared to S&P 500 - CML News
06/06/16 11:23 AMHC Trending Hot Stocks: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Vertex Pharmaceuticals Incorporated ... - share market updates (press release)
06/05/16 09:50 AMPerformance Review for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - HNN
06/03/16 10:16 AMEarnings Analysis to Watch: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Vishay Intertechnology Inc. (NYSE ... - Beacon Chronicle
06/02/16 07:45 PMVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Near Term Target Update - Stock Tick Tock - Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Near Term Target UpdateStock Tick TockSell-siders covering shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) have a consensus price target of $115.75 for the next 12-18 months. Analysts study the companies they cover in order to present the sell-side institutions with the ...and more »
06/01/16 07:57 PMEarnings in Focus: Chubb Limited (NYSE:CB), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - Beacon Chronicle - Beacon ChronicleEarnings in Focus: Chubb Limited (NYSE:CB), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Beacon ChronicleLast Trade: The Company closed its last session at $93.15 with the gain of 3.06%. The market capitalization of the company is $22.74 Billion, with the average Volume of 2.11 Million. The stock currently has its 52-Week High range of $143.45 and 52-week ...and more »
06/01/16 12:25 PMVertex Receives FDA Nod for Priority Review of Orkambi -
06/01/16 10:13 AMVertex Gets FDA's Priority Review For SNDA For Its ORKAMBI - Benzinga - Vertex Gets FDA's Priority Review For SNDA For Its ORKAMBIBenzingaVertex Pharmaceuticals Incorporated VRTX 1.74% revealed that the U.S. Food and Drug Administration has accepted its supplemental New Drug Application (sNDA) for priority review. According to the company, the review is for the use of ORKAMBI ...FDA accepts Vertex Pharma's application for expanded use of Orkambi; action date September 30Seeking Alphaall 9 news articles »
06/01/16 10:13 AMVertex Pharmaceuticals Incorporated (VRTX) Pops 3.06% for May 31 - Equities.com - iStreetWireVertex Pharmaceuticals Incorporated (VRTX) Pops 3.06% for May 31Equities.comOne of the S&P 500's big winners for Tuesday May 31 was Vertex Pharmaceuticals Incorporated (VRTX) as the company's stock climbed 3.06% to $93.15 on volume of 1.69 million shares. The stock opened at $90.62 and saw an intraday low of $90.61 and an ...Active Biotech Stock News: Geron Corporation (GERN), Vertex Pharmaceuticals Incorporated (VRTX)ZergwatchVertex Pharma (VRTX) Announces FDA Accepts sNDA for ORKAMBI in Children with CFStreetInsider.comAnalyst's Recommendation on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)CWRU ObserverCCH Daily News -The News Journalall 18 news articles »
06/01/16 07:28 AMVertex (VRTX) Orkambi sNDA Accepted with Priority Review -
05/31/16 07:37 PMEarnings Trends of the Stock: Neuralstem (CUR), Vertex Pharmaceuticals (VRTX) - Beacon Chronicle - Beacon ChronicleEarnings Trends of the Stock: Neuralstem (CUR), Vertex Pharmaceuticals (VRTX)Beacon ChronicleVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) currently has High Price Target of $ 155.00. The Low and Mean Price Targets are $ 75.00 and $ 109.55 respectively. These price targets are a consensus analysis of 20 brokers. When having a look at ...and more »
05/31/16 07:37 PMAnalysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) and Minerva ... - Analyst Ratings - Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) and Minerva ...Analyst RatingsIn a report issued on May 27, Brian Abrahams from Jefferies reiterated a Buy rating on Vertex Pharm. (NASDAQ: VRTX), with a price target of $103. The company's shares closed last Friday at $90.38. Abrahams said, “Our prescription analysis suggests ...and more »
05/31/16 07:37 PMCompany Update (NYSE:VRTX): FDA Grants Priority Review for Vertex Pharmaceuticals Incorporated's Supplemental ... - Smarter Analyst - Company Update (NYSE:VRTX): FDA Grants Priority Review for Vertex Pharmaceuticals Incorporated's Supplemental ...Smarter AnalystVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental New Drug Application (sNDA) for the use of ORKAMBI® (lumacaftor/ivacaftor) in people with cystic ...Vertex Gets FDA's Priority Review For SNDA For Its ORKAMBIBenzingaFDA accepts Vertex Pharma's application for expanded use of Orkambi; action date September 30Seeking Alphaall 10 news articles »
05/31/16 10:04 AMBiotech Movers Update: Endo International plc (NASDAQ:ENDP) , Vertex Pharmaceuticals Incorporated (NASDAQ ... - Is stories - Is storiesBiotech Movers Update: Endo International plc (NASDAQ:ENDP) , Vertex Pharmaceuticals Incorporated (NASDAQ ...Is storiesIn most recently trading session on 5/27/2016, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) climbed +1.33% while traded on 1.11 million shares versus it's an average volume of 2.13 million shares. The company recorded the last trade with the ...and more »
05/31/16 10:04 AMVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Quarterly EPS Estimate At $0.34 - Investor Newswire - Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Quarterly EPS Estimate At $0.34Investor NewswireFirst Call stated that Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) can touch $109.55 in coming one year. For the next quarter, the per-share earnings target is $0.34 and for ongoing fiscal at $1.07. EPS target for next year is $3.35 versus the ...and more »
05/31/16 10:04 AMVertex Pharma (VRTX) Announces FDA Accepts sNDA for ORKAMBI in Children with CF - StreetInsider.com - Vertex Pharma (VRTX) Announces FDA Accepts sNDA for ORKAMBI in Children with CFStreetInsider.comVertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental New Drug Application (sNDA) for the use of ORKAMBI® (lumacaftor/ivacaftor) in people with ...Vertex Gets FDA's Priority Review For SNDA For Its ORKAMBIBenzingaall 3 news articles »
05/31/16 08:52 AMVertex Gets FDA's Priority Review For SNDA For Its ORKAMBI - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) revealed that the U.S. Food and Drug Administration has accepted its supplemental New Drug Application (sNDA) for priority review. According to the company, the review is for the use of ORKAMBI (lumacaftor/ivacaftor) in people with cystic fibrosis (CF) ages 6 to 11 who have two copies of the F508del mutation. Vertex said that the regulator has approved its request for Priority Review of this sNDA, and a target review date of September 30, 2016 was set under the Prescription Drug User Fee ...Full story available on Benzinga.com
05/30/16 10:30 PMPrice Target in View Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - HNN - Price Target in View Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)HNNVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has been provided a consensus price target of $115.75 on shares. Out of all the Wall Street analysts polled by Zacks Research that were included for this target, the analyst with the highest price ...and more »
05/29/16 11:06 AMVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Impact Score At 87 - Stocks Daily - Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Impact Score At 87Stocks DailyAlpha One explored various online articles released on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), and it set a daily sentiment score of -0.35 on the company. The entity has an algorithm in place to know stock sentiment on the share after ...and more »
05/28/16 07:38 AMLast Week's Best Healthcare ETF -
About Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated logoVertex Pharmaceuticals Incorporated is engaged in the business of discovering, developing, manufacturing and commercializing medicines for serious diseases. The Company operates in pharmaceuticals segment. Its business is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs in other indications. Its marketed medicines are ORKAMBI and KALYDECO, which are approved to treat patients with CF having specific mutations in their CF transmembrane conductance regulator (CFTR) gene. It has multiple development programs in the field of CF, including VX-661, VX-371, and VX-152 and VX-440. It is engaged in various other research and mid- and early-stage development programs, such as programs in the areas of oncology, pain and neurology. Its oncology drug candidates include VX-970, VX-803 and VX-984; pain drug candidates include VX-150 and VX-241, and acute spinal cord injury drug candidate include VX-210.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: VRTX
  • CUSIP: 92532F10
Key Metrics:
  • Previous Close: $83.44
  • 50 Day Moving Average: $87.862
  • 200 Day Moving Average: $91.607
  • P/E Ratio: N/A
  • P/E Growth: 1.480
  • Market Cap: $20.66B
  • Current Quarter EPS Consensus Estimate: $1.110 EPS
Additional Links:
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Chart for Wednesday, June, 29, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha